文献速递血栓与止血

孤立性浅静脉血栓形成后静脉血栓栓塞复发的长期风险

Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
PubMed 文献 · J Thromb Haemost · 2017-05-05

基于前瞻性多中心观察性OPTIMEV研究,比较无癌症的首次孤立性浅静脉血栓形成(iSVT)患者(n=285)与首次近端深静脉血栓形成(DVT)患者(n=262)在停用抗凝药后3年内的静脉血栓栓塞(VTE)复发情况。结果显示iSVT患者总体VTE复发率与近端DVT患者相似,但复发为深静脉VTE的风险约为后者的半数,而复发为iSVT的风险约为后者的6倍。

要点

  • iSVT患者总体VTE复发率与近端DVT患者相似(5.4%/患者年 vs 6.5%/患者年,aHR 0.9,95%CI 0.5-1.6)。
  • iSVT复发为深静脉VTE事件的风险约为近端DVT患者的半数(2.5% vs 5.9%,aHR 0.4,95%CI 0.2-0.9)。
  • iSVT复发为iSVT的风险约为近端DVT患者的6倍(2.7% vs 0.6%,aHR 5.9,95%CI 1.3-27.1)。

核心结论

  • 在无癌症的首次iSVT患者中,停用抗凝药后深静脉VTE复发率约为近端DVT患者的一半,但总体复发风险相似。
  • 隐股交界受累似乎影响深静脉VTE复发风险,而静脉曲张状态对VTE复发无影响或影响较低。

研究设计与样本

  • 前瞻性、多中心、观察性OPTIMEV研究。
  • 纳入首次客观确诊的无癌症iSVT患者285例,以及首次近端DVT无癌症患者262例。
  • 在停用抗凝药后3年评估VTE复发(iSVT/DVT/PE)的发生率和类型。

主要发现

  • iSVT患者总体VTE复发率为5.4%/患者年,近端DVT患者为6.5%/患者年(aHR 0.9,95%CI 0.5-1.6)。
  • iSVT患者复发为iSVT的比例为2.7%,近端DVT患者为0.6%(aHR 5.9,95%CI 1.3-27.1)。
  • iSVT患者复发为深静脉VTE事件的比例为2.5%,近端DVT患者为5.9%(aHR 0.4,95%CI 0.2-0.9)。
  • 静脉曲张状态不影响VTE复发的风险或类型。
  • 隐股交界受累与复发风险升高无关(5.2%/患者年 vs 5.4%/患者年),但与复发仅表现为深静脉VTE事件相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials Long-term risk of recurrence of isolated superficial vein thrombosis (SVT) is under-studied. We analyzed data from a cohort of first SVT and proximal deep vein thrombosis (DVT) without cancer. The risk of recurrence as DVT or pulmonary embolism is twice lower in SVT patients. However, overall risk of recurrence is similar between SVT and proximal DVT patients. Click to hear Dr Decousus' perspective on superficial vein thrombosis SUMMARY: Background Isolated superficial vein thrombosis (iSVT) (without concomitant deep vein thrombosis [DVT] or pulmonary embolism [PE]) is a frequent event, but available data on long-term outcomes are scarce and retrospective. Therefore, we aimed to determine prospectively the risk and type of venous thromboembolism (VTE) recurrence after iSVT and compare them with those of proximal DVT. Methods Using data from the prospective, multicenter, observational, OPTIMEV study, we assessed, at 3 years and after anticoagulants were stopped, the incidence and the type of VTE recurrence (iSVT/DVT/PE) of patients with a first objectively confirmed iSVT without cancer (n = 285), and compared these with those of patients with a first proximal DVT without cancer (n = 262). Results As compared with proximal DVT patients, iSVT patients had a similar overall incidence of VTE recurrence (5.4% per patient-year [PY] versus 6.5% per PY, adjusted hazard ratio [aHR] 0.9, 95% confidence interval [CI] 0.5-1.6), but iSVT recurred six times more often as iSVT (2.7% versus 0.6%, aHR 5.9, 95% CI 1.3-27.1) and 2.5 times less often as deep-VTE events (2.5% versus 5.9%, aHR 0.4, 95% CI 0.2-0.9). Varicose vein status did not influence the risk or the type of VTE recurrence. Saphenian junction involvement by iSVT was not associated with a higher risk of recurrence (5.2% per PY versus 5.4% per PY), but was associated with recurrence exclusively as deep-VTE events. Conclusion In patients with a first iSVT without cancer, after stopping anticoagulants, the incidence of deep-VTE recurrence is half that of DVT patients, but the overall risk of recurrence is similar. Ssaphenian junction involvement seems to influence the risk of deep-VTE recurrence, whereas varicose vein status has no impact or a low impact on VTE recurrence.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Galanaud JP, Sevestre MA, Pernod G, et al. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. J Thromb Haemost. 2017. PMID: 28317330. doi:10.1111/jth.13679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。